FDA Approved: OZEMPIC — Supplemental Application (Novo Nordisk)

View source ↗

Summary

The FDA approved a supplemental application for OZEMPIC (semaglutide) from Novo Nordisk, which updates the drug's label and may add a new indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• OZEMPIC (semaglutide)

Snippet

SUPPL AP for OZEMPIC (SEMAGLUTIDE)